Appropriability and the Patenting Process: An Exploratory Analysis of Pharmaceuticals

dc.contributor.authorBarros, Henrique Machado
dc.coverage.cidadeSão Paulopt_BR
dc.coverage.paisBrasilpt_BR
dc.creatorBarros, Henrique Machado
dc.date.accessioned2023-07-17T19:35:55Z
dc.date.available2023-07-17T19:35:55Z
dc.date.issued2008
dc.description.abstractThe literature reports that patents are commonly seen as isolating mechanisms. Nevertheless, our knowledge as to how firms manage both patents and the patenting process to capture the benefits realised from innovative effort is still scant. In this paper we explore how firms use the patenting process to enhance appropriability conditions. Based upon case studies of six various sized UK pharmaceutical firms our findings suggest that it is mainly by managing a whole portfolio of patents that firms will generate the full benefits of patents and limit the operations of (potential) competitors. The portfolio approach is one alternative to broaden the scope of protection. Along the same lines our sample firms also revealed their interest in broader territorial coverage. Although the protection achieved is largely determined by the legal framework, firms revealed that the timing of application is pivotal in determining the scope of the final patent grant and other related follow-up patents.
dc.description.otherThe literature reports that patents are commonly seen as isolating mechanisms. Nevertheless, our knowledge as to how firms manage both patents and the patenting process to capture the benefits realised from innovative effort is still scant. In this paper we explore how firms use the patenting process to enhance appropriability conditions. Based upon case studies of six various sized UK pharmaceutical firms our findings suggest that it is mainly by managing a whole portfolio of patents that firms will generate the full benefits of patents and limit the operations of (potential) competitors. The portfolio approach is one alternative to broaden the scope of protection. Along the same lines our sample firms also revealed their interest in broader territorial coverage. Although the protection achieved is largely determined by the legal framework, firms revealed that the timing of application is pivotal in determining the scope of the final patent grant and other related follow-up patents.pt_BR
dc.format.extent25 p.pt_BR
dc.format.mediumDigitalpt_BR
dc.identifier.issueBEWP 025/2008
dc.identifier.urihttps://repositorio.insper.edu.br/handle/11224/5838
dc.language.isoInglêspt_BR
dc.publisherInsperpt_BR
dc.publisherIBMEC São Paulopt_BR
dc.relation.ispartofseriesInsper Working Paperpt_BR
dc.rights.licenseO INSPER E ESTE REPOSITÓRIO NÃO DETÊM OS DIREITOS DE USO E REPRODUÇÃO DOS CONTEÚDOS AQUI REGISTRADOS. É RESPONSABILIDADE DO USUÁRIO VERIFICAR OS USOS PERMITIDOS NA FONTE ORIGINAL, RESPEITANDO-SE OS DIREITOS DE AUTOR OU EDITORpt_BR
dc.subject.keywordsintellectual propertypt_BR
dc.subject.keywordspatentspt_BR
dc.subject.keywordspharmaceutical industrypt_BR
dc.subject.keywordsinnovationpt_BR
dc.subject.keywordsR&Dpt_BR
dc.titleAppropriability and the Patenting Process: An Exploratory Analysis of Pharmaceuticalspt_BR
dc.typeworking paper
dspace.entity.typePublication
local.subject.cnpqMultidisciplinarpt_BR
local.typeWorking Paperpt_BR

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
N/D
Nome:
BEWP_025_2008_Appropriability_and_the_patenting_process_an_exploratory_analysis_of_pharmaceuticals_TC.pdf
Tamanho:
219.43 KB
Formato:
Adobe Portable Document Format